BroadOak Asset Management provides investment management services exclusively to private investment pools focused on the life sciences sector. BroadOak invests in growth-stage life sciences companies seeking debt or minority equity financing. BroadOak does not tailor its advisory services to the needs of individual clients and does not permit clients to impose restrictions upon investments in certain types of securities.
BroadOak's fees are negotiated separately for each client, but are typically based on a percentage of the net capital committed. These fees generally do not exceed 2.5% and are typically paid quarterly in advance. BroadOak may also receive performance-based compensation, generally 20% or more of the fund's net capital appreciation, after deducting the base management fee. Clients also incur bank fees, audit fees, and legal fees.